Schedule 13G ownership disclosure

ATARA BIOTHERAPEUTICS INC

Security class unavailable · CUSIP: 046513107

Event date: 2017-12-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,154,540
Percent of class
3.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-17-062877
Form type
SC 13G
Filer
Atara Biotherapeutics, Inc.
CIK
CIK 1604464
Filed
Dec 08, 2017
Reporting period
Dec 05, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub